Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Alastair Boyd

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Lancet. Infectious Diseases|July 24, 2015
The LATTE study: a provocative brewMark Alastair Boyd, David A Cooper
Journal of Clinical Pharmacology|November 15, 2003
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtideMark Alastair Boyd, Xiaoping Zhang, Albert Dorr, et al.
The Medical Journal of Australia|February 19, 2019
Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004-2015Hamish McManus, Denton Callander, Basil Donovan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Lancet. Infectious Diseases|July 24, 2015
The LATTE study: a provocative brewMark Alastair Boyd, David A Cooper
Journal of Clinical Pharmacology|November 15, 2003
Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtideMark Alastair Boyd, Xiaoping Zhang, Albert Dorr, et al.
The Medical Journal of Australia|February 19, 2019
Early initiation of antiretroviral therapy for people newly diagnosed with HIV infection in Australia: trends and predictors, 2004-2015Hamish McManus, Denton Callander, Basil Donovan, et al.
Pageof 1